http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 22 Jun 2026 06:50:57 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Intl+Ratings/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY2%2C700+at+JPMorgan/26669607.html JPMorgan analyst Naoko Saito raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY2,700.00 (from JPY2,500.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY2%2C700+at+JPMorgan/26669607.html Mon, 22 Jun 2026 06:50:57 -0400 TRUMY http://www.streetinsider.com/Intl+Ratings/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY2%2C700+at+JPMorgan/26669607.html JPMorgan analyst Naoko Saito raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY2,700.00 (from JPY2,500.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY2%2C700+at+JPMorgan/26669607.html Mon, 22 Jun 2026 06:50:57 -0400 TRUMY http://www.streetinsider.com/Analyst+PT+Change/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY2%2C700+at+JPMorgan/26669607.html JPMorgan analyst Naoko Saito raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY2,700.00 (from JPY2,500.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY2%2C700+at+JPMorgan/26669607.html Mon, 22 Jun 2026 06:50:57 -0400 TRUMY http://www.streetinsider.com/Analyst+PT+Change/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY2%2C700+at+JPMorgan/26669607.html JPMorgan analyst Naoko Saito raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY2,700.00 (from JPY2,500.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY2%2C700+at+JPMorgan/26669607.html Mon, 22 Jun 2026 06:50:57 -0400 TRUMY http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Reiterates+Neutral+Rating+on+Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29/26649357.html <p>Goldman Sachs analyst Akinori Ueda reiterated a Neutral rating and JPY2,400.00 price target on Terumo Corp. (4543:JP) (OTC: TRUMY).</p> http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Reiterates+Neutral+Rating+on+Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29/26649357.html Tue, 16 Jun 2026 00:22:43 -0400 TRUMY http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Reiterates+Neutral+Rating+on+Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29/26649357.html <p>Goldman Sachs analyst Akinori Ueda reiterated a Neutral rating and JPY2,400.00 price target on Terumo Corp. (4543:JP) (OTC: TRUMY).</p> http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Reiterates+Neutral+Rating+on+Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29/26649357.html Tue, 16 Jun 2026 00:22:43 -0400 TRUMY http://www.streetinsider.com/Intl+Ratings/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY3%2C300+at+Citi/26552632.html Citi analyst Hidemaru Yamaguchi raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY3,300.00 (from JPY3,000.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY3%2C300+at+Citi/26552632.html Wed, 27 May 2026 05:32:52 -0400 TRUMY http://www.streetinsider.com/Intl+Ratings/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY3%2C300+at+Citi/26552632.html Citi analyst Hidemaru Yamaguchi raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY3,300.00 (from JPY3,000.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY3%2C300+at+Citi/26552632.html Wed, 27 May 2026 05:32:52 -0400 TRUMY http://www.streetinsider.com/Analyst+PT+Change/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY3%2C300+at+Citi/26552632.html Citi analyst Hidemaru Yamaguchi raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY3,300.00 (from JPY3,000.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY3%2C300+at+Citi/26552632.html Wed, 27 May 2026 05:32:52 -0400 TRUMY http://www.streetinsider.com/Analyst+PT+Change/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY3%2C300+at+Citi/26552632.html Citi analyst Hidemaru Yamaguchi raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY3,300.00 (from JPY3,000.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Raised+to+JPY3%2C300+at+Citi/26552632.html Wed, 27 May 2026 05:32:52 -0400 TRUMY http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Press+Releases/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html <p>OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer &amp; President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo http://www.streetinsider.com/Globe+Newswire/OrganOx+Announces+Appointment+of+Naoya+Iwata+as+CEO+%26amp%3B+President/26490214.html Thu, 14 May 2026 08:00:00 -0400 4543 A.50214830 A.50214881 O.04697602 O.05105687 O.71961715 TRUMY http://www.streetinsider.com/Intl+Ratings/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Lowered+to+JPY2%2C500+at+JPMorgan/26284968.html JPMorgan analyst Naoko Saito lowered the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY2,500.00 (from JPY2,700.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Terumo+Corp.+%284543%3AJP%29+%28TRUMY%29+PT+Lowered+to+JPY2%2C500+at+JPMorgan/26284968.html Wed, 08 Apr 2026 02:47:25 -0400 TRUMY